NCT03341520 2023-11-30
GAZAI
Heidelberg University
Phase 2 Unknown
Clinical Trials
5 trialsNCT05322733 2022-04-19
Orelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLL
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT04934930 2021-06-22
FLMRD
Meir Medical Center
Phase 2 Unknown
NCT02689869 2021-05-07
Alternative
Ludwig-Maximilians - University of Munich
Phase 2 Unknown
NCT03679455 2018-11-13
OBI-1
Polish Myeloma Consortium
Phase 2 Unknown